Commonwealth of Pennsylvania Public School Employees Retirement System’s Tvardi Therapeutics TVRD Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,328	Closed	-$235K	–	1688
2023 Q1	$235K	Sell	1,328 -14	-1%	-$4.69K	﹤0.01%	1699
2022 Q4	$519K	Buy	1,342 +200	+18%	+$76K	﹤0.01%	1529
2022 Q3	$385K	Buy	1,142 +70	+7%	+$25.4K	﹤0.01%	1707
2022 Q2	$352K	Buy	1,072 +69	+7%	+$24.2K	﹤0.01%	1735
2022 Q1	$439K	Buy	1,003 +116	+13%	+$47.6K	﹤0.01%	1716
2021 Q4	$389K	Buy	887 +1	+0.1%	+$502	﹤0.01%	1706
2021 Q3	$493K	Sell	886 -32	-3%	-$16.1K	0.01%	1586
2021 Q2	$471K	Buy	+918	New	+$582K	0.01%	1623

Other funds holding TVRD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's TVRD Position: Q2 2023 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 1,328 shares — an estimated $235K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $519K in Q4 2022. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Commonwealth of Pennsylvania Public School Employees Retirement System sold 1,328 Tvardi Therapeutics shares in Q2 2023, an estimated $235K.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
Commonwealth of Pennsylvania Public School Employees Retirement System's Tvardi Therapeutics position peaked at $519K in Q4 2022.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2023, filed 9 Aug 2023.